actinic keratosis

(redirected from Actinic Keratosis.)
Also found in: Dictionary, Medical.
Related to Actinic Keratosis.: actinic cheilitis
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to actinic keratosis

an overgrowth of skin layers resulting from extended exposure to the sun

Related Words

References in periodicals archive ?
Utility of step sections: demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis.
5% and 5% fluorouracil topical cream in patients with actinic keratosis.
But experts admitted the growths could be due to a pre-cancerous condition called actinic keratosis.
Annoying lesions that peel or flake indicate actinic keratosis.
75% cream) is a patented product for the treatment of actinic keratosis.
KX2-391, also known as KX-01, is a dual Src kinase and tubulin polymerization inhibitor and a first-in-class topical treatment of actinic keratosis.
The abstract is entitled Phase II Study of KX2-391 Ointment 1%, a Novel Field Treatment Based on Src/Tubulin Polymerization Inhibition, for Actinic Keratosis.
A blinded evaluator scored each side of each face, defining clearance as complete regression of actinic keratosis.
Dr Morton added that the most serious possibility was that the Queen had a pre-cancerous condition called actinic keratosis.
Imiquimod 5% cream, applied 3 times per week for 12 weeks, is effective for treatment of actinic keratosis.
On 29 November 2006, the European Commission granted permission for extension of Aldara's indications to include actinic keratosis.
05% is indicated for the topical treatment of actinic keratosis.
a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the recruitment of the first patient into one of two Phase III clinical trials of KX-01 ointment for the treatment of actinic keratosis.
21 October 2011 - German biotech Biofrontera (ETR:B8F) said on Friday that the European Medicines Agency (EMA) had adopted a favourable opinion on its marketing approval application for BF-200 ALA for the treatment of actinic keratosis.
The company is currently researching creams for nail fungus, dry and scaly skin, anal fissures, and actinic keratosis.